Polaris Capital Management LLC raised its position in UnitedHealth Group Inc (NYSE:UNH) by 5.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 200,742 shares of the healthcare conglomerate’s stock after buying an additional 9,987 shares during the quarter. UnitedHealth Group accounts for 2.7% of Polaris Capital Management LLC’s holdings, making the stock its 8th biggest holding. Polaris Capital Management LLC’s holdings in UnitedHealth Group were worth $53,405,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. FMR LLC grew its holdings in shares of UnitedHealth Group by 5.1% during the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after purchasing an additional 2,981,233 shares in the last quarter. Wells Fargo & Company MN grew its holdings in shares of UnitedHealth Group by 0.5% during the 2nd quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock worth $1,887,377,000 after purchasing an additional 39,480 shares in the last quarter. Jennison Associates LLC grew its holdings in shares of UnitedHealth Group by 12.0% during the 2nd quarter. Jennison Associates LLC now owns 6,616,652 shares of the healthcare conglomerate’s stock worth $1,623,329,000 after purchasing an additional 710,745 shares in the last quarter. Morgan Stanley grew its holdings in shares of UnitedHealth Group by 5.2% during the 2nd quarter. Morgan Stanley now owns 5,498,557 shares of the healthcare conglomerate’s stock worth $1,349,017,000 after purchasing an additional 269,652 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its holdings in shares of UnitedHealth Group by 2.8% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 4,019,885 shares of the healthcare conglomerate’s stock worth $986,239,000 after purchasing an additional 108,052 shares in the last quarter. 85.45% of the stock is currently owned by hedge funds and other institutional investors.
Shares of UNH stock opened at $281.36 on Friday. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.61. UnitedHealth Group Inc has a twelve month low of $208.48 and a twelve month high of $285.45. The firm has a market cap of $271.82 billion, a P/E ratio of 27.94, a price-to-earnings-growth ratio of 1.63 and a beta of 0.78.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be given a dividend of $0.90 per share. The ex-dividend date is Friday, November 30th. This represents a $3.60 annualized dividend and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio is currently 35.75%.
Several research firms have recently issued reports on UNH. Raymond James increased their target price on UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a report on Monday, September 24th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 11th. Piper Jaffray Companies increased their target price on UnitedHealth Group to $312.00 and gave the stock an “overweight” rating in a report on Wednesday. Citigroup lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 target price on the stock. in a report on Monday, September 10th. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $310.00 target price on shares of UnitedHealth Group in a report on Wednesday, November 21st. Two equities research analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $292.48.
In other UnitedHealth Group news, Director Richard T. Burke sold 6,090 shares of the stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total value of $1,715,674.80. Following the completion of the transaction, the director now directly owns 1,711,584 shares in the company, valued at $482,187,444.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kenneth Irwin Shine sold 163 shares of the stock in a transaction dated Friday, November 9th. The shares were sold at an average price of $274.83, for a total value of $44,797.29. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 60,428 shares of company stock valued at $16,232,134. 0.87% of the stock is owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Technical Analysis
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.